BioWorld

Oct. 27, 2014

CRO-sponsor partnerships require planning, time to develop

A report from Tufts Center for the Study of Drug Development (CSDD) highlights the evolving relationships between contract research organizations (CROs) and clinical trial sponsors through the adoption of strategic partnerships. Read More

Week in review

Word on the street

Week in Washington

Biotechnology company deals with other biotechnology companies: September 1 - October 23, 2014

Top 10 deals between biotech companies in 2014

Manufacturing, marketing and distribution agreements between biotech companies: September 1 - October 23, 2014

Biotech-biotech collaborations: modified agreements: September 1 - October 23, 2014

Money raised by biotech in 2014 vs. 2013

Money raised by biotech Jan. 1 - Oct. 23, 2014

The week's biggest gainers and losers

BioWorld stock report for public biotechnology companies

Today's news in brief

BioWorld

BioWorld briefs for Jan 23, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...